MiniMed Group, Inc. MMED
—
19.98
(0.46)
(2.25%)
as of 25 Sep
- Market cap
- $5.8B
- P/E
- 0.0×
Follow MMED
| Jul '26 | Apr '26 | Jan '26 | Jul '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | — | — | — |
+2 more TTM periods Free account |
|
| (6.27%) | 0.00% | 0.00% | — | ||
ROIC |
(1.61%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(10.80%) | 0.00% | 0.00% | — | |
Average Days of Receivables |
21.59 | 0.00 | 0.00 | — | |
Free Cash Flow per Share |
(1.61) | — | (1.74) | (1.40) | |
Free Cash Flow |
(452.00) | — | (441.00) | (354.00) | |
Capital Expenditures |
(318.00) | — | (413.00) | (394.00) | |
Piotroski F-Score |
1.00 | — | — | — | |
| Other line items | |||||
Cash ROIC |
(3.50%) | 0.00% | (0.81%) | 0.00% | |
Accounts Receivable Turnover |
0.00 | — | — | — | |
Accounts Payable Turnover |
0.00 | — | — | — | |
Inventory Turnover |
0.00 | — | — | — | |
Average Days of Payables |
64.88 | 0.00 | 0.00 | — | |
Days of Inventory on Hand |
92.03 | 0.00 | 0.00 | — | |
Tax Rate |
0.54 | — | — | — | |
Research and Development Expense of Revenue |
15.31% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
38.51% | — | — | — | |
Share Based Compensation of Revenue |
2.92% | — | — | — | |
Interest Coverage |
0.00 | — | — | — | |
Operating CF/Net income |
0.91 | — | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.32 | 0.00 | 0.43 | 0.00 | |
Capex/Depreciation |
(1.35) | — | (1.38) | (1.27) | |
Revenue per Share |
10.83 | — | 0.00 | 0.00 | |
Operating CF per Share |
(0.48) | — | (0.11) | 0.16 | |
Capex per Share |
(1.13) | — | (1.63) | (1.56) | |
Capex to Sales |
0.10 | — | 0.00 | 0.00 | |
Net Profit Margin |
(4.86%) | — | — | — |
Columns are period end dates